Table 3.
Characteristic | Hazard Ratio (95% CI) |
Cumulative Incidence (95% CI) |
|
---|---|---|---|
Age (years) | |||
<60 | 1 (referent) | 19.1 (16.0–22.3) | |
60–79 | 0.90 (0.71–1.14) | 17.4 (15.5–19.4) | |
≥80 | 1.07 (0.80–1.42) | 19.9 (16.9–22.8) | |
Sex | |||
Female | 1 (referent) | 20.2 (18.0–22.4) | |
Male | 0.83 (0.69–1.00) | 17.2 (15.4–19.1) | |
Hypertension | |||
No | 1 (referent) | 17.1 (14.7–19.5) | |
Yes | 1.15 (0.94–1.40) | 19.3 (17.5–21.1) | |
Diabetes mellitus | |||
No | 1 (referent) | 17.3 (15.8–18.8) | |
Yes | 1.34 (1.10–1.63) | 22.6 (19.5–25.6) | |
Chronic obstructive pulmonary disease | |||
No | 1 (referent) | 17.6 (16.2–19.0) | |
Yes | 1.43 (1.15–1.79) | 23.9 (19.9–27.9) | |
Current smoker | |||
No | 1 (referent) | 18.2 (16.7–19.7) | |
Yes | 1.11 (0.89–1.39) | 19.7 (16.4–22.9) | |
Cerebrovascular Disease | |||
No | 1 (referent) | 18.4 (16.9–19.9) | |
Yes | 1.04 (0.83–1.30) | 19.2 (15.8–22.5) | |
Heart failure | |||
No | 1 (referent) | 18.3 (16.8–19.8) | |
Yes | 1.12 (0.87–1.43) | 20.0 (16.2–23.7) | |
Body mass index (kg/m2) | |||
<20 | 1.03 (0.70–1.52) | 18.4 (12.9–23.9) | |
20 to 24.9 | 1.19 (0.94–1.50) | 20.1 (17.4–22.9) | |
25 to 29.9 | 1.07 (0.87–1.32) | 18.5 (16.2–20.8) | |
≥30 | 1 (referent) | 17.3 (14.9–19.7) | |
Type of myocardial infarction | |||
ST-segment elevation | 0.87 (0.71–1.06) | 17.1 (14.6–19.5) | |
Non ST-segment elevation | 1 (referent) | 19.2 (17.5–20.9) | |
Killip class | |||
1 | 1 (referent) | 17.6 (16.0–19.3) | |
2–4 | 1.22 (1.01–1.46) | 20.5 (17.9–23.0) | |
Angiography/ Reperfusion/revascularization | |||
Reperfusion/revascularization no complications | 1 (referent) | 16.8 (14.8–18.7) | |
Angiogram no complications | 1.13 (0.91–1.40) | 16.3 (12.8–19.8) | |
No angiogram/reperfusion/revascularization | 1.17 (0.92–1.48) | 18.7 (15.7–21.8) | |
Angiogram with complications | 2.40 (1.43–4.01) | 35.3 (21.6–49.0) | |
Reperfusion/ revascularization with complications | 2.12 (1.61–2.80) | 31.6 (25.4–37.9) | |
Anemia* | |||
No | 1 (referent) | 20.9 (18.3–23.6) | |
Yes | 1.26 (1.03–1.50) | 17.4 (15.8–19.1) | |
Estimated glomerular filtration rate (mL/min)* | |||
≥60 | 1 (referent) | 17.5 (15.4–19.6) | |
<60 | 1.13 (0.93–1.37) | 19.4 (17.4–21.3) | |
Length of stay during incident MI admission (days) | |||
0–3 | 1 (referent) | 14.4 (11.8–17.0) | |
4–7 | 1.34 (1.05–1.70) | 18.5 (16.4–21.7) | |
>7 | 1.65 (1.27–2.14) | 22.0 (19.3–24.7) | |
Year of diagnosis | |||
1987–92 | 1 (referent) | 18.6 (15.6–21.7) | |
1993–98 | 1.03 (0.80–1.33) | 18.7 (15.8–21.5) | |
1999–2004 | 1.02 (0.79–1.32) | 18.8 (16.2–21.3) | |
2005–10 | 0.98 (0.74–1.29) | 18.1 (15.3–20.9) |
The estimated cumulative incidence and 95% CI of readmission at 30 days for each characteristic are adjusted for all other variables shown as well as site of care. CI= confidence interval
Anemia and estimated glomerular filtration rate are based on hemoglobin and creatinine from laboratory measurements on the index MI date or the closest date when measured during the index admission.